Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
The American Journal of Pathology|August 17, 2021
Intussusceptive Angiogenesis in Human Metastatic Malignant MelanomaAnkur Pandita, Matias Ekstrand, Sara Bjursten, et al.
Nature Communications|April 22, 2020
Molecular profiling of driver events in metastatic uveal melanomaJoakim Karlsson, Lisa M Nilsson, Suman Mitra, et al.
Blood|June 4, 2010
Aurora kinases A and B are up-regulated by Myc and are essential for maintenance of the malignant stateJürgen den Hollander, Sara Rimpi, Joanne R Doherty, et al.
Nature Communications|August 28, 2021
The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanomaLars Ny, Henrik Jespersen, Joakim Karlsson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 20, 2023
Isolated Hepatic Perfusion With Melphalan for Patients With Isolated Uveal Melanoma Liver Metastases: A Multicenter, Randomized, Open-Label, Phase III Trial (the SCANDIUM Trial)Roger Olofsson Bagge, Axel Nelson, Amir Shafazand, et al.
Annals of Surgery|February 29, 2024
Survival and Quality of Life After Isolated Hepatic Perfusion With Melphalan as a Treatment for Uveal Melanoma Liver Metastases: Final Results From the Phase III Randomized Controlled Trial SCANDIUMRoger Olofsson Bagge, Axel Nelson, Amir Shafazand, et al.
JCO Precision Oncology|September 11, 2020
Mutational Signature and Transcriptomic Classification Analyses as the Decisive Diagnostic Tools for a Cancer of Unknown PrimaryRoger Olofsson Bagge, Akif Demir, Joakim Karlsson, et al.
Pigment Cell & Melanoma Research|June 24, 2026
Meeting Report From the 2025 Cure Ocular Melanoma (CURE OM) Global Science Meeting, Amsterdam, the Netherlands, October 2025Andrew E Aplin, Katherina Alsina, Allison S Betof, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 17, 2024
The effect of a single dose of nivolumab prior to isolated limb perfusion for patients with in-transit melanoma metastases: An interim analysis of a phase Ib/II randomized double-blind placebo-controlled trial (NivoILP trial)Carl-Jacob Holmberg, Lisanne P Zijlker, Dimitrios Katsarelias, et al.
The Journal of Clinical Investigation|September 17, 2024
Pericyte phenotype switching alleviates immunosuppression and sensitizes vascularized tumors to immunotherapy in preclinical modelsZhi-Jie Li, Bo He, Alice Domenichini, et al.
Pageof 10